Main > ONCOLOGY (**) > Gastric Cancer>MET HER2+ > TREAT.: > JP. D. TrastuzuMAb DeruxTecan Inj.

---

JP. D. TrastuzuMAb DeruxTecan Inj.'s subsections
(*) JP Approval Date: 2020. 09.25.
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2020. 09.22
TradeMark
TradeMark Web-Site

JP. D. TrastuzuMAb DeruxTecan Inj.'s products
This section has no products